- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00453869
Screening of Fibrosing and/or Viral Chronic Hepatopathies in Jail (SNIFF11)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Primary outcome: Screening of clinically significant fibrosis with FibroMeter blood score. Screening for hepatitis B and hepatitis C viruses.
Secondary outcome: Clinically significant fibrosis confirmed with FibroScan®.
The means for this study are a clinical questionnaire, a virological screening, a blood score for liver fibrosis: FibroMeter according to cause of the fibrosis and FibroScan® is referent and independent examination.
The expected results from this study are the knowledge of the prevalence of hepatopathies with hepatic fibrosis will be able to justify, possibly, a screening politic of them. This study will permit to evaluate the feasibility of noninvasive screening of the liver fibrosis in the goal to suppress the liver biopsy in a population having numerous drawbacks.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Angers, France, 49 933
- University Hospital Angers
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Person over 18,
- All new inmates, for less than one month, in Angers jail,
- To have a written informed consent.
Exclusion Criteria:
- No consent obtained from person,
- Detention inferior to one month,
- Person under 18.
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Liver fibrosis evaluation
Time Frame: D0
|
Evaluation of liver fibrosis with blood tests
|
D0
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Paul CALES, MD, PhD, UH Angers
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PHRC 2006-05
- DGS 2006-0142 ; CPP 2006/27bis
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Liver Fibrosis
-
Alentis Therapeutics AGRecruitingLiver Cirrhosis | Advanced Liver FibrosisUnited States, Germany, Romania, Slovakia
-
Bristol-Myers SquibbCompleted
-
University Hospital, AngersRecruitingScreening | Advanced Liver FibrosisFrance
-
University Hospital, GrenobleNot yet recruiting
-
The Affiliated Hospital of Qingdao UniversityRecruitingLiver Fibrosis After Liver Transplantation | Multiparameter Magnetic Resonance ImagingChina
-
Assistance Publique - Hôpitaux de ParisUnknownLiver Fibrosis Progression in Chronic Liver DiseaseFrance
-
Regina Elena Cancer InstituteFederico II UniversityRecruiting
-
Gilead SciencesTerminatedLiver Fibrosis Due to NASHUnited States, Canada, France, Italy, Germany, Puerto Rico, Spain, United Kingdom
-
Seoul National University HospitalCompletedLiver Fibroses | Liver MassKorea, Republic of
-
Olympus Corporation of the AmericasGeisinger ClinicCompleted
Clinical Trials on liver fibrosis evaluation
-
Institut de Médecine et d'Epidémiologie Appliquée...CompletedHIV | Liver Fibrosis | Abdominal Obesity Metabolic Syndrome
-
University Hospital, MontpellierNot yet recruitingPsychiatric Disorder | Liver Fibrosis | Advanced Chronic Liver Disease | Psychiatric HospitalizationFrance
-
European Institute of OncologyRecruitingCardiomyopathy Due to DrugItaly
-
RenJi HospitalRecruitingLiver Transplant; Complications | Liver Fibrosis | Pediatric DisorderChina
-
RenJi HospitalNot yet recruiting
-
Institute of Tropical Medicine, BelgiumUniversity Hospital, Antwerp; Sihanouk Hospital Center of HOPETerminated
-
University Hospital, Clermont-FerrandUnknownMRI | Liver Fibrosis | Liver Biopsy | IVIMFrance
-
Centre Hospitalier Universitaire de NiceCompletedNon Alcoholic Fatty Liver DiseaseFrance
-
University Hospital OstravaUniversity of OstravaCompleted
-
Centre Hospitalier Universitaire, AmiensUnknownSquamous Cell Carcinoma of the Head and Neck | Liver Cirrhoses | Liver FibrosesFrance